Article result template
I'm a little template short and blank. I link to void and keep hidden out.
2024-08-09T23:34:19+0100
ResMed
Macro Intelligence: ResMed's strong Q4 earnings propel shares to one-year high
ResMed shares surge to a one-year high following impressive 4Q earnings and a 10% dividend increase. With analysts rating the stock a "BUY", CEO Mick Farrell views the impact of weight loss drugs as a growth opportunity.
2024-08-07T01:33:30+0100
AU market earnings: ResMed's robust performance
ResMed reports a significant revenue rise of 9% to $1.22 billion USD in the June quarter, highlighting its strong market position despite concerns over weight loss drugs impacting product demand.
2024-08-05T08:13:42+0100
Stock of the day: ResMed
Despite the challenges posed by GLP-1 weight loss drugs, ResMed's Q2 report shows a robust 9% increase in revenue and strong earnings per share, signaling a promising future and making it a compelling buy for investors.
2024-08-02T06:44:52+0100
